Today: 16 July 2026
Decent Holding (DXST) stock price jumps 80% on huge volume as lock-up ends, reverse split vote nears
12 February 2026
1 min read

Decent Holding (DXST) stock price jumps 80% on huge volume as lock-up ends, reverse split vote nears

New York, Feb 11, 2026, 18:28 EST — Trading after the bell

Decent Holding Inc soared nearly 80% Wednesday, last changing hands at $0.31 after hours. The day was volatile: shares swung from $0.17 up to $0.48, with trading volume blasting past 307 million.

The timing comes as the Nasdaq-listed firm preps for a shareholder vote on consolidating its stock—essentially, a reverse split that groups several shares into one, raising the per-share price though the business itself remains unchanged. In its proxy, Decent requested investor approval for a broad range: anywhere from a 5-to-1 up to a 50-to-1 ratio, leaving the specifics and the scheduling in the board’s hands. The company stated the move is intended to “increase the per-share trading price.”

Why it matters now: Decent is warning it needs to stay compliant with Nasdaq requirements, especially those related to its share price. The company says there’s no assurance it can keep meeting those standards. Shares are stuck well under $1—a threshold closely watched by Nasdaq investors.

Tuesday’s action also came with a short-term overhang: MarketScreener data, sourcing S&P Capital IQ, highlighted 11.25 million Class A shares locked up from Nov. 12 through Feb. 10. Those restrictions barred certain holders—typically insiders—from selling during that 90-day stretch after the offering.

The feed also highlighted 5 million Class B shares with a lock-up set to expire on Feb. 10. Lock-up expiration dates tend to draw traders’ attention—freshly unlocked stock may boost supply, though it’s never certain holders will actually sell.

The lock-up stems from a registered offering wrapped up in November, according to a press release. The company sold 13.33 million Class A shares at $0.60 apiece and handed out warrants covering up to 26.67 million additional shares. Warrants let holders buy stock later at a fixed price—potentially diluting existing shareholders if exercised.

Decent disclosed in a February filing that it let go of audit firm WWC, P.C. and brought on YCM CPA Inc. as its independent registered public accounting firm, effective Dec. 15, 2025. According to the company, WWC’s audit reports for fiscal 2023 and 2024 carried neither an adverse opinion nor a disclaimer.

Decent, based in the Cayman Islands, operates in China via a subsidiary that handles industrial wastewater treatment, river restoration, and produces microbial products aimed at improving water quality, the company’s investor relations site shows.

The stock trades at a low price and lacks heft, making it prone to sudden technical swings—particularly when corporate actions come into play. Consolidating shares might bump up the sticker price, but this maneuver doesn’t alter the company’s underlying value. What it can do is squeeze liquidity, since fewer shares will be out there.

Eyes will be on the stock Thursday to see if it maintains the brisk trading pace. Investors are also looking for fresh filings before the Feb. 23 shareholder meeting, where the direction—and potentially the timing—of the proposed consolidation will be decided.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • DENTSPLY SIRONA (XRAY) Closes Above Analyst Target at $41.44
    July 16, 2026, 9:27 AM EDT. DENTSPLY SIRONA Inc (NASDAQ: XRAY) ended the session at $41.44, edging past analysts' 12-month average target of $41.22. Some analysts could revisit their price targets after the move, either cutting or bumping up projections depending on the company's outlook. Targets run from $37 to $47, with a $3.83 standard deviation, showing a mixed take. Consensus still sits at 2.25, where 1 means strong buy and 5 is strong sell. With XRAY above target, investors are looking at the next move as they weigh gains against valuation concerns.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff
Previous Story

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop